Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ahmed A. Othman
Safety, Tolerability, and Pharmacodynamics of ABT-122, a TNF- And IL-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With RA
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Exposure‐Response Relationships for Efficacy and Safety of Risankizumab in Phase 2 and 3 Trials in Psoriasis Patients
Clinical Pharmacology and Therapeutics
Pharmacology
Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
Clinical Pharmacology and Therapeutics
Pharmacology
Exposure‐Response Analyses of Upadacitinib Efficacy and Safety in Phase 2 and 3 Studies to Support Benefit‐Risk Assessment in Rheumatoid Arthritis
Clinical Pharmacology and Therapeutics
Pharmacology
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication
Clinical Pharmacokinetics
Pharmacology
Lack of Effect of 12-Week Treatment With Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical Pharmacokinetics
Pharmacology
Development of in Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
AAPS Journal
Pharmaceutical Science
